|
|
|
|
pmid:19020988
|
| Jansen EE et al. |
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development. |
2008 |
BMC Dev. Biol. |
pmid:19040727
|
|
|
|
|
pmid:19169842
|
|
|
|
|
pmid:19194588
|
|
|
|
|
pmid:19283509
|
|
|
|
|
pmid:19444541
|
|
|
|
|
pmid:19474378
|
| Wang Y and Zhang YH |
Cell-free protein synthesis energized by slowly-metabolized maltodextrin. |
2009 |
BMC Biotechnol. |
pmid:19558718
|
| Engqvist M et al. |
Two D-2-hydroxy-acid dehydrogenases in Arabidopsis thaliana with catalytic capacities to participate in the last reactions of the methylglyoxal and beta-oxidation pathways. |
2009 |
J. Biol. Chem. |
pmid:19586914
|
| Van Deun K et al. |
A structured overview of simultaneous component based data integration. |
2009 |
BMC Bioinformatics |
pmid:19671149
|
|
|
|
|
pmid:19727923
|
|
|
|
|
pmid:19760480
|
| Dang L et al. |
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. |
2009 |
Nature |
pmid:19935646
|
| Kranendijk M et al. |
Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria. |
2010 |
Hum. Mutat. |
pmid:20020533
|
|
|
|
|
pmid:20052767
|
| Bleeker FE et al. |
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. |
2010 |
Acta Neuropathol. |
pmid:20127344
|
| Frezza C et al. |
IDH1 mutations in gliomas: when an enzyme loses its grip. |
2010 |
Cancer Cell |
pmid:20129244
|
|
|
|
|
pmid:20141220
|
| Maxmen A |
Cancers converge at 2-HG. |
2010 |
J. Exp. Med. |
pmid:20142426
|
| Gross S et al. |
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. |
2010 |
J. Exp. Med. |
pmid:20142433
|
|
|
|
|
pmid:20168250
|
| Ward PS et al. |
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. |
2010 |
Cancer Cell |
pmid:20171147
|
|
|
|
|
pmid:20305482
|
| Calduch-Giner JA et al. |
Use of microarray technology to assess the time course of liver stress response after confinement exposure in gilthead sea bream (Sparus aurata L.). |
2010 |
BMC Genomics |
pmid:20307314
|
|
|
|
|
pmid:20335593
|
|
|
|
|
pmid:20367200
|
| Abdel-Wahab O and Levine RL |
Metabolism and the leukemic stem cell. |
2010 |
J. Exp. Med. |
pmid:20368582
|
|
|
|
|
pmid:20393698
|
|
|
|
|
pmid:20421813
|
| Tefferi A |
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. |
2010 |
Leukemia |
pmid:20428194
|
| Mardis ER |
Cancer genomics identifies determinants of tumor biology. |
2010 |
Genome Biol. |
pmid:20441611
|
| Zhang C and Gänzle MG |
Metabolic pathway of α-ketoglutarate in Lactobacillus sanfranciscensis and Lactobacillus reuteri during sourdough fermentation. |
2010 |
J. Appl. Microbiol. |
pmid:20477886
|
| Patnaik MM et al. |
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. |
2010 |
Leukemia |
pmid:20485371
|
| Araújo WL et al. |
Identification of the 2-hydroxyglutarate and isovaleryl-CoA dehydrogenases as alternative electron donors linking lysine catabolism to the electron transport chain of Arabidopsis mitochondria. |
2010 |
Plant Cell |
pmid:20501910
|
| Tefferi A et al. |
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. |
2010 |
Leukemia |
pmid:20508616
|
| Reitman ZJ and Yan H |
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. |
2010 |
J. Natl. Cancer Inst. |
pmid:20513808
|
| Dang L et al. |
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. |
2010 |
Nature |
pmid:20559394
|
|
|
|
|
pmid:20576929
|
|
|
|
|
pmid:20615753
|
|
|
|
|
pmid:20659156
|
|
|
|
|
pmid:20692206
|
|
|
|
|
pmid:20699614
|
| Yang I and Liau LM |
American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA. |
2010 |
J. Neurooncol. |
pmid:20714783
|
| Riemenschneider MJ et al. |
Molecular diagnostics of gliomas: state of the art. |
2010 |
Acta Neuropathol. |
pmid:20714900
|
| Kranendijk M et al. |
IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. |
2010 |
Science |
pmid:20847235
|
|
|
|
|
pmid:20852250
|
|
|
|
|
pmid:20859647
|
|
|
|
|
pmid:20962328
|
|
|
|
|
pmid:20972461
|
|
|
|
|
pmid:20975740
|
| Seltzer MJ et al. |
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. |
2010 |
Cancer Res. |
pmid:21045145
|
| O'Keefe LV et al. |
Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. |
2011 |
Hum. Mol. Genet. |
pmid:21075834
|
|
|
|
|
pmid:21080253
|
| Bosch AM et al. |
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. |
2011 |
J. Inherit. Metab. Dis. |
pmid:21110228
|
| Figueroa ME et al. |
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. |
2010 |
Cancer Cell |
pmid:21130701
|
| Paravati AJ et al. |
Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. |
2011 |
J. Neurooncol. |
pmid:21181233
|
| Lu Y et al. |
Chloroplast 2010: a database for large-scale phenotypic screening of Arabidopsis mutants. |
2011 |
Plant Physiol. |
pmid:21224340
|
|
|
|
|
pmid:21225914
|
| Xu W et al. |
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. |
2011 |
Cancer Cell |
pmid:21251613
|
| Brauburger K et al. |
The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons. |
2011 |
J. Inherit. Metab. Dis. |
pmid:21264516
|
| Kones R |
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. |
2010 |
Drug Des Devel Ther |
pmid:21267417
|
|
|
|
|
pmid:21284999
|
| Reitman ZJ et al. |
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21289278
|
|
|
|
|
pmid:21294161
|
| Engqvist MK et al. |
Plant D-2-hydroxyglutarate dehydrogenase participates in the catabolism of lysine especially during senescence. |
2011 |
J. Biol. Chem. |
pmid:21296880
|
| Frezza C et al. |
Inborn and acquired metabolic defects in cancer. |
2011 |
J. Mol. Med. |
pmid:21301796
|
| Chovatia M et al. |
Complete genome sequence of Thermanaerovibrio acidaminovorans type strain (Su883). |
2009 |
Stand Genomic Sci |
pmid:21304665
|
| Chang YJ et al. |
Complete genome sequence of Acidaminococcus fermentans type strain (VR4). |
2010 |
Stand Genomic Sci |
pmid:21304687
|
| Araújo WL et al. |
Antisense inhibition of the iron-sulphur subunit of succinate dehydrogenase enhances photosynthesis and growth in tomato via an organic acid-mediated effect on stomatal aperture. |
2011 |
Plant Cell |
pmid:21307286
|
| Jin G et al. |
2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations. |
2011 |
PLoS ONE |
pmid:21326614
|
| Kölker S et al. |
Diagnosis and management of glutaric aciduria type I--revised recommendations. |
2011 |
J. Inherit. Metab. Dis. |
pmid:21431622
|
| Parthasarathy A et al. |
Substrate specificity of 2-hydroxyglutaryl-CoA dehydratase from Clostridium symbiosum: toward a bio-based production of adipic acid. |
2011 |
Biochemistry |
pmid:21434666
|
| Kochevenko A and Fernie AR |
The genetic architecture of branched-chain amino acid accumulation in tomato fruits. |
2011 |
J. Exp. Bot. |
pmid:21436187
|
|
|
|
|
pmid:21446021
|
| Chowdhury R et al. |
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. |
2011 |
EMBO Rep. |
pmid:21460794
|
| Zhang Y |
Biology of the Mi-2/NuRD Complex in SLAC (Stemness, Longevity/Ageing, and Cancer). |
2011 |
Gene Regul Syst Bio |
pmid:21523247
|
|
|
|
|
pmid:21524095
|
|
|
|
|
pmid:21554053
|
| Ramezani M et al. |
Glutamate racemization and catabolism in Fusobacterium varium. |
2011 |
FEBS J. |
pmid:21575137
|
| Yan W et al. |
Oncogene addiction in gliomas: implications for molecular targeted therapy. |
2011 |
J. Exp. Clin. Cancer Res. |
pmid:21575270
|
| Krell D et al. |
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma. |
2011 |
PLoS ONE |
pmid:21625441
|
| Fong MY et al. |
Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. |
2011 |
PLoS ONE |
pmid:21625518
|
|
|
|
|
pmid:21631627
|
|
|
|
|
pmid:21641335
|
| Passamonti F et al. |
Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies. |
2011 |
Oncotarget |
pmid:21646683
|
| Lages E et al. |
MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. |
2011 |
PLoS ONE |
pmid:21655185
|
| Saccenti E et al. |
Simplivariate models: uncovering the underlying biology in functional genomics data. |
2011 |
PLoS ONE |
pmid:21698241
|
| Bralten LB et al. |
Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomas. |
2011 |
PLoS ONE |
pmid:21760942
|
| Marie SK and Shinjo SM |
Metabolism and brain cancer. |
2011 |
Clinics (Sao Paulo) |
pmid:21779721
|
| Scott JG et al. |
Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift? |
2011 |
Neuro-oncology |
pmid:21784755
|
| Araújo WL et al. |
Analysis of a range of catabolic mutants provides evidence that phytanoyl-coenzyme A does not act as a substrate of the electron-transfer flavoprotein/electron-transfer flavoprotein:ubiquinone oxidoreductase complex in Arabidopsis during dark-induced senescence. |
2011 |
Plant Physiol. |
pmid:21788362
|
| Fathi AT and Abdel-Wahab O |
Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy. |
2012 |
Adv Hematol |
pmid:21811504
|
| Ohka F et al. |
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. |
2011 |
PLoS ONE |
pmid:21829728
|
|
|
|
|
pmid:21857150
|
| Khorassani R et al. |
Citramalic acid and salicylic acid in sugar beet root exudates solubilize soil phosphorus. |
2011 |
BMC Plant Biol. |
pmid:21871058
|
|
|
|
|
pmid:21885076
|
| Kranendijk M et al. |
A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: novel avenues for biochemical and therapeutic studies. |
2011 |
Biochim. Biophys. Acta |
pmid:21889589
|
| Haffner MC et al. |
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. |
2011 |
Oncotarget |
pmid:21896958
|
| Tefferi A et al. |
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. |
2012 |
Leukemia |
pmid:21912393
|
| Capper D et al. |
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size. |
2012 |
Int. J. Cancer |
pmid:21913188
|
